TABLE 2.
Demographic and clinical features of the total cohort
| Clinical Feature | Total cohort n = 44a |
|---|---|
| Age (years), mean (SD) | 60 (12) |
| Sex, Male, n (%) | 35 (80) |
| Race/Ethnicity, n, (%) | |
| White (Non-Hispanic) | 20 (46) |
| Black | 8 (18) |
| Asian | 5 (11) |
| Hispanic (White + Non-White) | 10 (23) |
| Other | 1 (2) |
| Etiology, n (%) | |
| Ischemic Cardiomyopathy | 17 (39) |
| Non-Ischemic Cardiomyopathy | 27 (61) |
| Body mass index, mean (SD) | 25 (5.2) |
| Charlson comorbidity index (CCI), median (range) | 4 |
| Mechanical circulatory support pre-transplant, n (%) | 2 (4) |
| On inotropes pre-transplant, n (%) | 19 (43) |
| Sequential Organ Failure Assessment (SOFA) Score, median (range) | 3 (0-10) |
| Days of initial hospitalization, mean (SD) | 25.5 (17.8) |
| Short Physical Performance Battery (SPPB)a | 7 (1-12) |
| Fried Frailty Phenotype (FFP)a | 3 (0-5) |
| Frailty Risk Score (FRS) | 7 (2-13) |
| Listed, n (%) | 25 (57) |
| Transplanted, n (%) | 14 (32) |
| Deceased, n (%) | 12 (27) |
a
SPPB and FFP had n = 41 and n = 40, respectively.